Cullen/Frost Bankers’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-23,414
Closed -$4.98M 405
2014
Q4
$4.98M Sell
23,414
-356
-1% -$70.8K 0.19% 136
2014
Q3
$4.24M Sell
23,770
-1,282
-5% -$213K 0.17% 135
2014
Q2
$4.24M Sell
25,052
-17,058
-41% -$2.66M 0.17% 145
2014
Q1
$5.23M Sell
42,110
-912
-2% -$111K 0.22% 129
2013
Q4
$4.78M Sell
43,022
-2,277
-5% -$217K 0.21% 132
2013
Q3
$4.1M Sell
45,299
-3,060
-6% -$275K 0.2% 141
2013
Q2
$4.07M Buy
+48,359
New +$5.02M 0.21% 142

Other funds holding AGN

Cullen/Frost Bankers's AGN Position: Q1 2015 in Review

Cullen/Frost Bankers sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 23,414 shares — an estimated $4.98M sold.

Cullen/Frost Bankers first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $5.23M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Cullen/Frost Bankers reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Cullen/Frost Bankers sold 23,414 Allergan Inc shares in Q1 2015, an estimated $4.98M.
  • Cullen/Frost Bankers first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Cullen/Frost Bankers's Allergan Inc position peaked at $5.23M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Cullen/Frost Bankers's 13F filing for Q1 2015, filed 4 May 2015.